Shares of Alkyl Amines Chemicals jumped as much as 9% on Tuesday, August 4, following the company's exceptional Q1 FY2026 results announcement. According to CNBC TV18, the stock ended 6% higher at ₹1,933 after the results announcement, with the stock up 20% so far this year. The strong market response reflects investor confidence in the company's robust financial performance and operational improvements during the quarter. As of August 4, 2026, the stock is trading at ₹1,921.20 with a 52-week range of ₹1,212.00 to ₹2,283.90, giving the company a market capitalization of ₹98.49 billion. The stock has a dividend yield of 0.56% and EPS (TTM) of ₹35.15.
Alkyl Amines Chemicals delivered exceptional financial performance in the quarter ended June 2026, with standalone net profit surging 91.40% to ₹94.63 crore compared to ₹49.44 crore in the corresponding quarter of the previous year. As reported by CNBC TV18, this represents a significant improvement in the company's bottom-line performance during the first quarter of fiscal 2026. The company also reported a gain from inventory changes of ₹48 crore during the quarter, compared with an expense of ₹1.5 crore in the corresponding period last year, supporting overall profitability. The company operates in the Basic Materials sector with a P/E ratio of 51.7x compared to the sector average of 34.7x, indicating premium valuation based on current market expectations.
The company's sales revenue increased by 30.20% to ₹528.01 crore in Q1 FY2026, up from ₹405.53 crore in the same quarter of the previous financial year. According to CNBC TV18, this substantial revenue growth demonstrates the company's strong market position and operational efficiency during the quarter. The company manufactures and supplies aliphatic amines, amine derivatives, and specialty chemicals in India and internationally, serving pharmaceutical, agro-chemicals, water treatment chemicals, rubber chemicals, and other industries. Total expenses increased to ₹412.6 crore from ₹347.2 crore in the year-ago period, while finance costs remained largely stable at ₹0.4 crore.
The company's EBITDA climbed 74.5% to ₹133.6 crore from ₹76.6 crore a year ago, with EBITDA margin expanding to 25.3% from 18.9%, reflecting improved operating performance. As reported by CNBC TV18, this improvement in operational efficiency contributed significantly to the overall profit growth, indicating better cost management and operational leverage during the quarter. Raw material costs rose to ₹316.1 crore from ₹218.3 crore, while employee benefit expenses increased to ₹36.3 crore from ₹27.3 crore, and other expenses also climbed to ₹90.1 crore from ₹81.8 crore. The company has 733 employees and has split 2 times in the past, with the stock trading on the India National Stock Exchange under symbol ALKY.
Separately, the board approved a comprehensive leadership restructuring to support the company's long-term growth and succession planning. According to CNBC TV18, Yogesh M. Kothari will be re-designated as Executive Chairman, while Kirat M. Patel and Suneet Y. Kothari will become Joint Managing Directors with effect from October 1, 2026, subject to shareholder approval. The board also approved the re-designation and appointment of Rakesh Goyal as Executive Director – Operations for a five-year term beginning April 1, 2027. The company continues to operate in a single business segment, Speciality Chemicals, with financial results reported on a standalone basis as it has no subsidiaries, associates or joint ventures. The company was incorporated in 1979 and is headquartered in Navi Mumbai, India.
